DK3354665T3 - Modificerede alginater til celleindkapsling og celleterapi - Google Patents

Modificerede alginater til celleindkapsling og celleterapi Download PDF

Info

Publication number
DK3354665T3
DK3354665T3 DK18162427.1T DK18162427T DK3354665T3 DK 3354665 T3 DK3354665 T3 DK 3354665T3 DK 18162427 T DK18162427 T DK 18162427T DK 3354665 T3 DK3354665 T3 DK 3354665T3
Authority
DK
Denmark
Prior art keywords
cell
enclosure
modified alginates
therapy
cell therapy
Prior art date
Application number
DK18162427.1T
Other languages
English (en)
Other versions
DK3354665T5 (da
Inventor
Kaitlin M Bratlie
Robert S Langer
Minglin Ma
Daniel G Anderson
Arturo J Vegas
Original Assignee
Massachusetts Inst Technology
Childrens Medical Ct Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology, Childrens Medical Ct Corp filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of DK3354665T3 publication Critical patent/DK3354665T3/da
Publication of DK3354665T5 publication Critical patent/DK3354665T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK18162427.1T 2011-06-02 2012-06-04 Modificerede alginater til celleindkapsling og celleterapi DK3354665T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161492705P 2011-06-02 2011-06-02
EP12728887.6A EP2714747B1 (en) 2011-06-02 2012-06-04 Modified alginates for cell encapsulation and cell therapy

Publications (2)

Publication Number Publication Date
DK3354665T3 true DK3354665T3 (da) 2022-04-25
DK3354665T5 DK3354665T5 (da) 2022-09-19

Family

ID=46321466

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18162427.1T DK3354665T5 (da) 2011-06-02 2012-06-04 Modificerede alginater til celleindkapsling og celleterapi

Country Status (7)

Country Link
US (6) US9422373B2 (da)
EP (3) EP2714747B1 (da)
CA (1) CA2837558C (da)
DK (1) DK3354665T5 (da)
ES (1) ES2912545T3 (da)
HK (1) HK1259279A1 (da)
WO (1) WO2012167223A1 (da)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112999429B (zh) * 2014-08-01 2022-07-22 麻省理工学院 用于抗纤维化材料的修饰的藻酸盐以及应用
EP3267965A4 (en) * 2015-03-11 2018-11-14 Atta Behfar Exosome delivery technology
MX2018005420A (es) 2015-11-01 2018-06-06 Massachusetts Inst Technology Alginatos modificados para materiales anti-fibroticos y aplicaciones.
KR102558416B1 (ko) * 2015-11-01 2023-07-24 메사추세츠 인스티튜트 오브 테크놀로지 개선된 특성을 가진 물질
US10697972B2 (en) 2016-01-12 2020-06-30 Bioatla, Llc Diagnostics using conditionally active antibodies
EP3403098B1 (en) 2016-01-12 2021-09-22 BioAtla, Inc. Diagnostics using conditionally active antibodies
US9999640B2 (en) 2016-02-02 2018-06-19 University Of Dammam Microencapsulated probiotic bacteria
US10046985B2 (en) 2016-02-11 2018-08-14 King Fahd University Of Petroleum And Minerals Method for removing cationic dyes from an aqueous solution using an adsorbent
EP4151661A1 (en) * 2016-03-24 2023-03-22 Takeda Pharmaceutical Company Limited Alginate hydrogel compositions
CA3027856A1 (en) 2016-06-13 2017-12-21 Massachusetts Institute Of Technology Surface-coated continuous glucose monitors
EP3512500A1 (en) * 2016-09-14 2019-07-24 Ecole Polytechnique Federale de Lausanne (EPFL) Hydrogels based on functionalized polysaccharides
EP3295933A1 (en) 2016-09-14 2018-03-21 Ecole Polytechnique Federale De Lausanne (Epfl) Hydrogels based on functionalized polysaccharides
WO2018140834A1 (en) * 2017-01-27 2018-08-02 Cornell University Zwitterionically modified polymers and hydrogels
WO2018232027A1 (en) 2017-06-13 2018-12-20 Massachusetts Institute Of Technology Biocompatible microfabricated devices for transplanting cells
MX2020003351A (es) 2017-09-27 2020-10-12 Sigilon Therapeutics Inc Metodos, composiciones y elementos implantables que comprenden celulas activas.
US11318231B2 (en) 2017-11-06 2022-05-03 Massachusetts Institute Of Technology Anti-inflammatory coatings to improve biocompatibility of neurological implants
EP3759154A1 (en) 2018-03-02 2021-01-06 Sigilon Therapeutics, Inc. Biocompatible hydrogel capsules and process for preparing same
CN112105612A (zh) 2018-03-02 2020-12-18 西吉隆医疗股份有限公司 抗纤维化化合物、装置及其用途
CA3096742A1 (en) * 2018-03-16 2019-09-19 Nutech Ventures Cell expansion system
JP2021520374A (ja) 2018-04-04 2021-08-19 シギロン セラピューティクス， インコーポレイテッドＳｉｇｉｌｏｎ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． 移植可能な粒子及び関連方法
US20210145889A1 (en) 2018-04-04 2021-05-20 Sigilon Therapeutics, Inc. Methods, compositions, and implantable elements comprising stem cells
KR20210019441A (ko) * 2018-06-14 2021-02-22 모찌다 세이야쿠 가부시끼가이샤 신규 가교 알긴산
US20210353781A1 (en) * 2018-09-21 2021-11-18 Massachusetts Institute Of Technology Surface-modified cells, methods of making and using
UY38389A (es) 2018-09-27 2020-04-30 Sigilon Therapeutics Inc Dispositivos implantables para terapia celular y métodos relacionados
US20220143270A1 (en) 2019-02-15 2022-05-12 William Marsh Rice University Vascularizing devices and methods for implanted diagnostics and therapeutics
JP7236533B2 (ja) 2019-04-09 2023-03-09 富士フイルム株式会社 マイクロカプセルの製造方法およびコート液
JP7431247B2 (ja) 2019-08-23 2024-02-14 富士フイルム株式会社 ミクロカプセルと細胞構造体とを含む組成物
EP4126001A1 (en) * 2020-04-02 2023-02-08 Cornell University Nanofiber-enabled encapsulation devices and uses thereof
EP3940072A1 (en) * 2020-07-13 2022-01-19 Biomillenia SAS Alginate beads and production thereof
US20220089537A1 (en) 2020-09-18 2022-03-24 Massachusetts Institute Of Technology High-throughput method to rapidly add chemical moieties to a small molecule library
WO2023230524A1 (en) 2022-05-25 2023-11-30 Flagship Pioneering Innovations Vi, Llc Compositions of secretory and/or catalytic cells and methods using the same
WO2023235884A1 (en) 2022-06-03 2023-12-07 Flagship Pioneering Innovations Vi, Llc Compositions and methods
WO2024006528A1 (en) 2022-07-01 2024-01-04 Sigilon Therapeutics, Inc. Covalently photocrosslinked polysaccharides and methods of use thereof
WO2024081309A1 (en) 2022-10-11 2024-04-18 Sigilon Therapeutics, Inc. Engineered cells and implantable elements for treatment of disease

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB676618A (en) * 1947-09-12 1952-07-30 Kelco Co Alkylene glycol esters of alginic acid
GB768309A (en) * 1954-03-27 1957-02-13 Henkel & Cie Gmbh Process for the production of amides of alginic acid
US2860130A (en) * 1954-11-01 1958-11-11 Kelco Co Methyl alginate
US2881161A (en) * 1955-03-25 1959-04-07 Henkel & Cie Gmbh Amides of alginic acid
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
NO845059L (no) 1984-12-17 1986-06-18 Sintef Inst For Marin Biokjemi Fremgangsmaate for fremstilling av alginater med endrede fysikalske egenskaper samt anvendelse av disse alginater.
IT1203814B (it) 1986-06-30 1989-02-23 Fidia Farmaceutici Esteri dell'acido alginico
JP2643669B2 (ja) 1990-12-28 1997-08-20 共成製薬株式会社 アルギン含有食品
US5876452A (en) 1992-02-14 1999-03-02 Board Of Regents, University Of Texas System Biodegradable implant
GB2270920B (en) * 1992-09-25 1997-04-02 Univ Keele Alginate-bioactive agent conjugates
FR2699545B1 (fr) * 1992-12-18 1995-01-27 Oreal Agent gélifiant résultant de l'association d'un chitosane et d'un alginate d'alkyle ou d'hydroxyalkyle et son utilisation dans la préparation de compositions cosmétiques et pharmaceutiques.
EP2025353A2 (en) 1993-04-30 2009-02-18 Massachusetts Institute of Technology Injectable polysaccharide-cell compositions
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US6171232B1 (en) 1997-06-26 2001-01-09 Cordis Corporation Method for targeting in vivo nitric oxide release
US6440940B1 (en) 1997-12-18 2002-08-27 Peter J. Doyle Bioresorbable alginate derivatives
US6159531A (en) 1999-08-30 2000-12-12 Cardiovasc, Inc. Coating having biological activity and medical implant having surface carrying the same and method
US6932894B2 (en) 2001-05-15 2005-08-23 Therasense, Inc. Biosensor membranes composed of polymers containing heterocyclic nitrogens
US6977138B2 (en) 2001-07-24 2005-12-20 Massachusetts Institute Of Technology Reactive polymer coatings
ES2330326T3 (es) 2002-05-24 2009-12-09 Angiotech International Ag Composiciones y metodos para recubrir implantes medicos.
US7008476B2 (en) * 2003-06-11 2006-03-07 Az Electronic Materials Usa Corp. Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof
US7329531B2 (en) 2003-12-12 2008-02-12 Scimed Life Systems, Inc. Blood-tight implantable textile material and method of making
DE602004029928D1 (de) 2003-12-23 2010-12-16 Fmc Biopolymer As Verwendung von alginat-matrizen zur kontrolle des zellwachstums
ITMI20041373A1 (it) * 2004-07-09 2004-10-09 Lima Lto S P A N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido
BRPI0517800A (pt) 2004-11-12 2008-10-21 Fmc Biopolymer As processo para preparar um polìmero de alginato modificado, polìmero de alginato modificado, e, gel ou fibra de alginato
ES2377479T3 (es) * 2005-09-27 2012-03-28 Universite Joseph Fourier - Grenoble 1 Hidrogel funcionalizado con una porción polimerizable y sus utilizaciones como biosensores o biorreactores.
DE102005049833A1 (de) 2005-10-14 2007-04-19 Beiersdorf Ag Hydrophob modifizierte Alginate
US8067237B2 (en) 2005-12-13 2011-11-29 President And Fellows Of Harvard College Scaffolds for cell transplantation
US8211361B2 (en) 2007-03-26 2012-07-03 Board Of Regents, The University Of Texas System N-halamine-based rechargeable biofilm-controlling tubular devices, method of making and using
US7515808B2 (en) 2007-06-01 2009-04-07 Alcatel-Lucent Usa Inc. Thermally stabilized waveguides
KR20100063744A (ko) 2007-08-28 2010-06-11 에프엠씨 코포레이션 지연된 자가-겔화 알기네이트 시스템 및 이의 용도
US7998524B2 (en) 2007-12-10 2011-08-16 Abbott Cardiovascular Systems Inc. Methods to improve adhesion of polymer coatings over stents
EP2127689A1 (en) 2008-05-27 2009-12-02 RevisiOs B.V. i.o. Novel homogenous osteoinductive nanocomposites
CN101565469B (zh) * 2008-10-28 2011-05-11 中国海洋大学 酰胺接枝的海藻酸钠纳米材料及其制备方法与应用
EP2356167A4 (en) 2008-12-12 2012-07-11 Univ Massachusetts POLYESTER WITH POTTED TWITTERS
JP2012517284A (ja) 2009-02-09 2012-08-02 セント ジュード メディカル インコーポレイテッド 医療デバイスの生体適合性の向上
US9555154B2 (en) 2009-02-21 2017-01-31 Covidien Lp Medical devices having activated surfaces
WO2011045443A1 (en) 2009-10-16 2011-04-21 Dsm Ip Assets B.V. Coatings comprising bis-(alpha-amino-diol-diester) containing polyesteramide
JP5876045B2 (ja) 2010-07-12 2016-03-02 ユニバーシティー オブ サザン カリフォルニア 幹細胞と標的組織の相互接続を促進する生体適合性基材およびそれを埋め込む方法
US20120083767A1 (en) 2010-10-01 2012-04-05 The Johns Hopkins University Implantable bioreactor for delivery of paracrine factors
JP5963130B2 (ja) 2012-02-16 2016-08-03 学校法人同志社 生体組織補強材料キット及び生体組織補強材料

Also Published As

Publication number Publication date
WO2012167223A1 (en) 2012-12-06
EP3354665B9 (en) 2022-08-03
CA2837558C (en) 2018-11-20
US20190262272A1 (en) 2019-08-29
US20210186886A1 (en) 2021-06-24
EP2714747B1 (en) 2020-08-05
EP3354665B1 (en) 2022-03-30
US20230130084A1 (en) 2023-04-27
EP4083074A1 (en) 2022-11-02
US20160324793A1 (en) 2016-11-10
DK3354665T5 (da) 2022-09-19
HK1259279A1 (zh) 2019-11-29
US10842753B2 (en) 2020-11-24
EP2714747A1 (en) 2014-04-09
US20120308650A1 (en) 2012-12-06
US20170239190A1 (en) 2017-08-24
US10292936B2 (en) 2019-05-21
ES2912545T3 (es) 2022-05-26
US10285949B2 (en) 2019-05-14
US11337930B2 (en) 2022-05-24
EP3354665A1 (en) 2018-08-01
CA2837558A1 (en) 2012-12-06
US9422373B2 (en) 2016-08-23

Similar Documents

Publication Publication Date Title
DK3354665T3 (da) Modificerede alginater til celleindkapsling og celleterapi
DK2950535T3 (da) Fremgangsmåde og indretning til at afkode intra-forudsigelsestilstand
DK3622883T3 (da) Indførerer til medicinsk indretning og fremgangsmåder til at indføre og anvende medicinske indretninger
DK3045187T3 (da) Injektor og fremgangsmåde til samling
DK3578201T3 (da) Fremgangsmåder og sammensætninger til naturlige dræberceller
DK3468197T3 (da) Fremgangsmåde til interforudsigelse og indretning dertil
DK3689878T3 (da) 4-imidazopyridazin-1-yl-benzamider og 4-imidazotriazin-1-yl-benzamider som btk-inhibitorer
DK2857401T3 (da) Hidtil ukendt -lactamaseinhibitor og fremgangsmåde til at fremstille samme
DK3202760T3 (da) Pegylerede lipider og deres anvendelse til lægemiddelfremføring
DK2624567T3 (da) Blokinddelingsfremgangsmåde og afkodningsindretning
DK2428450T3 (da) Doseringsmetode og doseringsindretning
DK2855736T3 (da) Elektrolysator og energisystem
DK2854883T3 (da) Biomatrix-hydrogeler og fremgangsmåder til anvendelse deraf
DK3597644T3 (da) Kationiske aminlipider og anvendelser deraf
DK3257943T3 (da) Fremgangsmåder og vektorer til celleimmortalisering
DK2699562T3 (da) Bicykliske heterocykliske forbindelser og anvendelser deraf ved terapi
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
CO7020866A2 (es) Péptidos terapéuticos
DK3197164T3 (da) Afkodningsanordning og afkodningsfremgangsmåde
DK2675827T3 (da) Hidtil ukendte modulatorer og fremgangsmåder til anvendelse
DK2683731T3 (da) C4-monomethyl-triterpenoidderivater og fremgangsmåder til anvendelse deraf
DK2705143T3 (da) Protein-induceret pluripotent celleteknologi og anvendelse deraf
DK2758655T3 (da) Systemer og fremgangsmåder til forbedrede vandrotorer
DK2666475T3 (da) Terapeutisk middel til skaldethed
DK2584921T3 (da) Sondeernæringspakninger og fremgangsmåder til anvendelse deraf